Expert Panel Mixed on Macroeconomic Indexing of Drug Cost; Govt Urged to Quit Targeting Pharma for Savings

MHLW Expert Panel on Comprehensive Pharmaceutical Policies on April 4 As Japan ponders ways to incentivize innovation and stem drug supply concerns, questions remain on where to find funding. Some members of a key expert panel urge the government to...read more